H. pylori and lung cancer
August 04, 2022
To explore H.
News
C. difficile may contribute to colorectal cancer: study
July 28, 2022
The findings from human colon cancer specimens, culturing, and mouse models were reported last month by researchers at VUMC and Johns Hopkins University in the journal Cancer Discovery.
Study reveals need for matching targeted therapies with EGFR subtypes
July 28, 2022
New research from Vanderbilt investigators suggests that clinicians should take a deeper dive into distinguishing EGFR mutations when prescribing targeted therapies for non-small-cell lung cancers.
Vanderbilt team tracks cellular and antibody responses to COVID-19 vaccine
July 21, 2022
The group used multiple single-cell technologies, unbiased machine learning, and traditional immunological approaches to track cellular and antibody responses in samples.
VIGH, VICC establish cancer research program in Zambia
July 21, 2022
New partnership will develop a cadre of researchers and educators to lead cancer epidemiology research and training in Zambia.
Clinic offers ongoing care for pediatric heart patients
July 15, 2022
The new multidisciplinary Fontan Clinic, led by Angela Weingarten, MD, will provide a coordinated care plan for children and teens.
Probing the tumor microenvironment
July 15, 2022
VUMC's Robert Coffey, MD, is among authors of a new study reported in Frontiers in Oncology, that provides important insight into the tumor microenvironment
Preempting sudden cardiac death
July 07, 2022
Inherited syndromes arising from rare genetic variants that cause cardiac arrhythmia (abnormal heart rhythm) are the most common cause of unexplained sudden death in people 15 to 30 years old. Yet it is difficult to distinguish benign (harmless) variants from those that are pathogenic.
Breaking the stigma of AIDS part of Raffanti’s long legacy
July 07, 2022
On June 29 Stephen Raffanti, MD, MPH, hung up his scrubs at the Vanderbilt Comprehensive Care Clinic for the last time. It was a bittersweet moment for the man who helped lead Nashville out of the darkest days of the AIDS epidemic 30 years ago.
Study shows genotype leads to discontinued, decreased medication
July 01, 2022
Patients whose race is recorded as Black in their electronic health record (EHR) are more likely to have azathioprine, an immunosuppressant medication, discontinued or its dose reduced because their laboratory results show a low white blood cell count.